Citations

Showing 10 of 108081 citations.

High-Throughput Processing to Preserve Viable Cells: A Precision Medicine Initiative Cohort Program Workshop
Rasooly, Rebekah S. , Gossett, Daniel R., Henderson, Marianne K. , Hubel, Allison , Thibodeau, Stephen N.

Mayo Clinic

Biopreservation and Biobanking | April 25, 2017 | Volume: 15 | Issue: 4 | Pages: 341-343

10.1089/bio.2017.0016 | PMID 28441039 Get It

Message from the Mirc President
Çïçek, Sertaç

Mayo Clinic

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | April 25, 2017 | Volume: 12 | Issue: 1_suppl | Pages: S1-S1

10.1097/imi.0000000000000364 | PMID 28441158 Get It

Sodium‐glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta‐analysis
Ruanpeng, Darin , Ungprasert, Patompong , Sangtian, Jutarat, Harindhanavudhi, Tasma

Mayo Clinic

Diabetes/Metabolism Research and Reviews | April 25, 2017 | Volume: 33 | Issue: 6 | Pages: No page available

10.1002/dmrr.2903 | PMID 28440590 Get It

AbstractBackgroundSodium‐glucose cotransporter 2 (SGLT2) inhibitors could potentially alter calcium and phosphate homeostasis and may increase the risk of bone fracture.MethodsThe current meta‐analysis was conducted to investigate the fracture risk among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors. Randomized controlled trials that compared the efficacy of SGLT2 inhibitors to placebo were identified. The risk ratios of fracture among patients who received SGLT2 inhibitors versus placebo were extracted from each study. Pooled risk ratios and 95% confidence intervals were calculated using a random‐effect, Mantel‐Haenszel analysis.ResultsA total of 20 studies with 8286 patients treated with SGLT2 inhibitors were included. The pooled risk ratio of bone fracture in patients receiving SGLT2 inhibitors versus placebo was 0.67 (95% confidence interval, 0.42‐1.07). The pooled risk ratio for canagliflozin, dapagliflozin, and empagliflozin was 0.66 (95% confidence interval, 0.37‐1.19), 0.84 (95% confidence interval, 0.22‐3.18), and 0.57 (95% confidence interval, 0.20‐1.59), respectively.ConclusionsIncreased risk of bone fracture among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors compared with placebo was not observed in this meta‐analysis. However, the results were limited by short duration of treatment/follow‐up and low incidence of the event of interest.
Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α‐synuclein pathology
Koga, Shunsuke , Ono, Maiko , Higuchi, Makoto , Sahara, Naruhiko , Dickson, Dennis W. , Koga, Shunsuke

Mayo Clinic

Movement Disorders | April 25, 2017 | Volume: 32 | Issue: 6 | Pages: 884-892

10.1002/mds.27013 | PMID 28440890 Get It

ABSTRACTBackground: The tau PET ligand 2‐((1E,3E)‐4‐(6‐([11C]methylamino)pyridin‐3‐yl)buta‐1,3‐dienyl)benzo[d]thiazol‐6‐ol ([11C]PBB3) binds to a wide range of tau pathology; however, binding property of PBB3 to non‐tau inclusions remains unknown. To clarify whether [11C]PBB3 binds to α‐synuclein pathology, reactivity of PBB3 was assessed by in vitro fluorescence and autoradiographic labeling of brain sections from α‐synucleinopathies patients.Method: Of 10 pure Lewy body disease and 120 multiple system atrophy (MSA) cases in the Mayo Clinic brain bank, we selected 3 Lewy body disease and 4 MSA cases with a range of α‐synuclein severity based on the quantitative analysis of α‐synuclein burden. PBB3 fluorescence labeling, double or single immunostaining for α‐synuclein and phospho‐tau, Prussian blue staining, and in vitro autoradiography with [11C]PBB3 were performed for these selected samples.Results: PBB3 fluorescence labeled various α‐synuclein lesions including Lewy bodies, Lewy neurites, spheroids, glial cytoplasmic inclusions, and neuronal cytoplasmic inclusions. Meanwhile, autoradiographic labeling with [11C]PBB3 at 10 nM demonstrated no significant binding in Lewy body disease cases. In contrast, significant autoradiographic binding of [11C]PBB3 to the striatopallidal fibers was found in 2 MSA cases, which had high densities of glial cytoplasmic inclusions without tau or iron deposits in this region.Conclusions: Given that the maximum concentration of [11C]PBB3 in human PET scans is approximately 10 nM, the present data imply that α‐synuclein pathology in Lewy body disease is undetectable by [11C]PBB3‐PET, whereas those in a subset of MSA cases with high densities of glial cytoplasmic inclusions could be captured by this radioligand. © 2017 International Parkinson and Movement Disorder Society
Intramuscular fat infiltration evaluated by magnetic resonance imaging predicts the extensibility of the supraspinatus muscle
Giambini, Hugo , Gorny, Krzysztof R. , Widholm, Per , Karlsson, Anette , Leinhard, Olof Dahlqvist , Adkins, Mark C., Zhao, Chunfeng , An, Kai‐Nan, Hatta, Taku, Hatta, Taku , An, Kai‐Nan

Mayo Clinic

Muscle & Nerve | April 25, 2017 | Volume: 57 | Issue: 1 | Pages: 129-135

10.1002/mus.25673 | PMID 28439938 Get It

ABSTRACTIntroduction: Rotator cuff (RC) tears result in muscle atrophy and fat infiltration within the RC muscles. An estimation of muscle quality and deformation, or extensibility, is useful in selecting the most appropriate surgical procedure. We determined if noninvasive quantitative assessment of intramuscular fat using MRI could be used to predict extensibility of the supraspinatus muscle. Methods: Seventeen cadaveric shoulders were imaged to assess intramuscular fat infiltration. Extensibility and histological evaluations were then performed. Results: Quantitative fat infiltration positively correlated with histological findings and presented a positive correlation with muscle extensibility (r = 0.69; P = 0.002). Extensibility was not significantly different between shoulders graded with a higher fat content versus those with low fat when implementing qualitative methods. Discussion: A noninvasive prediction of whole‐muscle extensibility may directly guide pre‐operative planning to determine if the torn edge could efficiently cover the original footprint while aiding in postoperative evaluation of RC repair. Muscle Nerve 57: 129–135, 2018
The utility of MASS‐FIX to detect and monitor monoclonal proteins in the clinic
Milani, Paolo , Murray, David , Barnidge, David R. , Kohlhagen, Mindy , Mills, John R. , Merlini, Giampaolo , Dasari, Surendra , Murray, David L., Kohlhagen, Mindy C, Dispenzieri, Angela , Merlini, Giampaolo , Milani, Paolo

Mayo Clinic

American Journal of Hematology | April 25, 2017 | Volume: 92 | Issue: 8 | Pages: 772-779

10.1002/ajh.24772 | PMID 28439985 Get It

The detection and quantification of monoclonal‐proteins (M‐proteins) are necessary for the diagnosis and evaluation of response in plasma cell dyscrasias. Immunoglobulin enrichment‐coupled with matrix‐assisted laser desorption ionization time‐of‐flight mass‐spectrometry (MASS‐FIX) is a simple and inexpensive method to identify M‐proteins, but its clinical generalizability has not yet been elucidated. We compared MASS‐FIX to protein electrophoresis (PEL), serum/urine immunofixation‐electrophoresis (IFE), and quantitative serum free‐light chain (FLC) for the identification of M‐proteins in different clinical diagnoses. Paired serum and urine samples from 257 patients were tested. There were six patients for whom s‐IFE and FLC ratio were positive and serum MASS‐FIX was negative, but when serum and urine MASS‐FIX results were combined, only one patient with light chain‐MGUS was missed. Serum/urine‐MASS‐FIX detected M‐proteins in 18 patients with negative serum/urine‐PEL/IFE and serum‐FLC, 10 of whom had multiple myeloma or AL amyloidosis, who were mistakenly thought to have complete hematologic response by serum/urine‐PEL/IFE and serum‐FLC. Nearly half of the AL amyloidosis patients had atypical spectra, which may prove to be a clue to the diagnosis and pathogenesis of the disease. In conclusion, MASS‐FIX has a comparable sensitivity with PEL/IFE/FLC methods and can help inform the clinical diagnosis.
Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis
Muchtar, Eli , Dean, Diana S., Dingli, David , Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Russell, Stephen J. , Lust, John A., Lin, Yi , Warsame, Rahma , Kourelis, Taxiarchis , Chakraborty, Rajshekhar , Zeldenrust, Steven R., Kyle, Robert A. , Kumar, Shaji , Muchtar, E , Dispenzieri, Angela , Buadi, Francis K. , Leung, Nelson , Gonsalves, Wilson I. , Go, Ronald S. , Rajkumar, S. Vincent , Gertz, Morie A. , Russell, Stephen J , Chakraborty, Rajshekhar , Dingli, David , Lin, Yi

Mayo Clinic

Journal of Internal Medicine | April 25, 2017 | Volume: 281 | Issue: 6 | Pages: 611-619

10.1111/joim.12617 | PMID 28439924 Get It

AbstractBackgroundData on the effect of systemic immunoglobulin light chain amyloidosis (AL amyloidosis) on thyroid function are limited.ObjectiveTo assess the prevalence of hypothyroidism in AL amyloidosis patients and determine its predictors.Methods1142 newly diagnosed AL amyloidosis patients were grouped based on the thyroid‐stimulating hormone (TSH) measurement at diagnosis: hypothyroid group (TSH above upper normal reference; >5 mIU L−1; n = 217, 19% of study participants) and euthyroid group (n = 925, 81%). Predictors for hypothyroidism were assessed in a binary multivariate model. Survival between groups was compared using the log‐rank test and a multivariate analysis.ResultsPatients with hypothyroidism were older, more likely to present with renal and hepatic involvement and had a higher light chain burden compared to patients in the euthyroid group. Higher proteinuria in patients with renal involvement and lower albumin in patients with hepatic involvement were associated with hypothyroidism. In a binary logistic regression model, age ≥65 years, female sex, renal involvement, hepatic involvement, kappa light chain restriction and amiodarone use were independently associated with hypothyroidism. Ninety‐three per cent of patients in the hypothyroid group with free thyroxine measurement had normal values, consistent with subclinical hypothyroidism. Patients in the hypothyroid group had a shorter survival compared to patients in the euthyroid group (4‐year survival 36% vs 43%; P = 0.008), a difference that was maintained in a multivariate analysis.ConclusionA significant proportion of patients with AL amyloidosis present with hypothyroidism, predominantly subclinical, which carries a survival disadvantage. Routine assessment of TSH in these patients is warranted.
Measuring the Needs of Family Caregivers of People With Dementia: An Assessment of Current Methodological Strategies and Key Recommendations
Bangerter, Lauren R. , Havyer, Rachel D. , Griffin, Joan M. , Havyer, Rachel, Zarit, Steven Howard

Mayo Clinic

Journal of Applied Gerontology | April 25, 2017 | Volume: 38 | Issue: 9 | Pages: 1304-1318

10.1177/0733464817705959 | PMID 28438063 Get It

While dementia caregivers are regarded as a population with high unmet needs, there is little consensus as to how caregivers’ needs should be conceptualized and measured. This article describes how dementia caregivers’ needs are currently assessed in the scientific literature with the goal of suggesting guidelines for the enhancement of future measurement of caregiver needs. A review of 26 articles identified overarching themes within measurement approaches including variation in methodological rigor, proxy indicators of need, dual needs assessment of caregiver and person with dementia (PWD), and third-party needs assessment. We recommend future research dedicate theoretical attention to the conceptualization and classification of caregivers’ needs to build a stronger foundation for measurement. The measurement development process should capitalize on mixed-methodology and follow instrument development and validation guidelines set forth by measurement theory. Reliable and valid instruments are essential to developing services and policies that address dementia caregivers’ needs.
Longitudinal characterization of renal proximal tubular markers in normotensive and preeclamptic pregnancies
Codsi, Elisabeth , Milić, Nataša , Borowski, Kristi, Rose, Carl H., Davies, Norman, Garovic, Vesna D. , Gonzalez-Suarez, Maria L, Borowski, Kristi S, Davies, Norman P, White, Wendy M, Suarez, Maria Lourdes Gonzalez , Kashani, Kianoush , Lieske, John C. , White, Wendy , Milic, N

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | April 25, 2017 | Volume: 312 | Issue: 5 | Pages: R773-R778

10.1152/ajpregu.00509.2016 | PMID 28438765 Get It

Glomerular damage is common in preeclampsia (PE), but the extent and etiology of tubular injury are not well understood. The aim of this study was to evaluate tubular injury in patients with PE and to assess whether it predates clinical disease. We performed a prospective cohort study of 315 pregnant women who provided urine samples at the end of the second trimester and at delivery. This analysis included women who developed PE ( n = 15), gestational hypertension (GH; n = 14), and normotensive controls (NC; n = 44). Urinary markers of tubular injury, α1-microglobulin (A1M), retinol-binding protein (RBP), kidney-injury molecule-1 (KIM1), complement C5b-9, tissue inhibitor metalloproteinase-2 (TIMP-2), and insulin-like growth factor binding protein-7 (IGFBP-7) were measured by enzyme-linked immunosorbent assay (ELISA) and reported in relation to urine creatinine concentration. Second-trimester concentrations of all markers were similar among groups. At delivery, A1M concentrations were higher in the PE group than in the GH and NC groups as an A1M/creatinine ratio >13 (66.7, 8.3, and 35%, respectively, P = 0.01). Concentrations of C5b-9 were higher in the PE group than in the GH and NC groups (medians 9.85, 0.05, and 0.28 ng/mg, respectively, P = 0.003). KIM1, RBP, TIMP-2, and IGFBP-7 concentrations did not differ among groups at delivery. In conclusion, proximal tubular dysfunction, as assessed by A1M and C5b-9, developed during the interval between the end of the second trimester and delivery in patients with PE. However, this was not matched by abnormalities in markers previously associated with tubular cell injury (KIM-1, IGFBP-7, and TIMP-2).